跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REDDY-AZACITIDINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
REDDY-AZACITIDINE
Authorized
STANDARD
REDDY-AZACITIDINE
dr reddy's laboratories ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
0b564f6ba8fccaed
Company
dr reddy's laboratories ltd
Type
Standard
Approval Details
Approval Id
0b564f6ba8fccaed
Drug Approval Canada Name
REDDY-AZACITIDINE
Product Name
REDDY-AZACITIDINE
Status
Cancelled Post Market
Status Date
2023-06-27
Original Market Date
2017-10-25
Din
02463199
Drug Class
Human
Dosage Form
Powder For Suspension
Route Of Administration
Subcutaneous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01BC07 AZACITIDINE
Atc Name
l 01 bc 07
Aig Number
0152665001
Company Name
dr reddy's laboratories ltd
Company Address
Survey Nos. 42, 45, 46 & 54, Innovation Plaza, Bachupally, Medchal-Malkajgiri, Telangana, India, 500090
Active Ingredients
AZACITIDINE
100 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
0b564f6ba8fccaed
Type
Standard
Back to Health Canada Approvals